Fennec Pharmaceuticals (FENC) Return on Assets (2011 - 2025)

Fennec Pharmaceuticals (FENC) has 15 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, down 1.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2024 and bottomed at 0.01% in Q2 2023.
• The 5-year median for Return on Assets is 0.01% (2021), against an average of 0.01%.
• The widest annual swing landed in 2021, when Return on Assets changed 0 bps; it then gained 1 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2021, then retreated by 14 bps to 0.01% in 2022, then gained by 18 bps to 0.01% in 2023, then jumped by 101 bps to 0.0% in 2024, then sank by 1445 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison